1. Home
  2. EYPT vs ITRN Comparison

EYPT vs ITRN Comparison

Compare EYPT & ITRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$13.35

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Ituran Location and Control Ltd.

ITRN

Ituran Location and Control Ltd.

HOLD

Current Price

$59.25

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYPT
ITRN
Founded
1987
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Electronic Components
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2005
2005

Fundamental Metrics

Financial Performance
Metric
EYPT
ITRN
Price
$13.35
$59.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$31.80
$60.67
AVG Volume (30 Days)
724.3K
99.9K
Earning Date
05-06-2026
05-26-2026
Dividend Yield
N/A
3.61%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,539,000.00
N/A
Revenue This Year
N/A
$12.38
Revenue Next Year
$3,115.57
$8.21
P/E Ratio
N/A
$16.85
Revenue Growth
N/A
N/A
52 Week Low
$5.57
$32.71
52 Week High
$19.11
$62.31

Technical Indicators

Market Signals
Indicator
EYPT
ITRN
Relative Strength Index (RSI) 50.32 60.29
Support Level $12.66 $54.64
Resistance Level $13.32 $62.31
Average True Range (ATR) 0.74 1.63
MACD -0.03 -0.32
Stochastic Oscillator 58.08 52.29

Price Performance

Historical Comparison
EYPT
ITRN

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

About ITRN Ituran Location and Control Ltd.

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.

Share on Social Networks: